Wisconsin Gov. Scott Walker has signed the state’s breast density reporting legislation into law. Providers that perform mammography are now required to send a notice to patients when it is determined they have dense breast tissue.

Mammography interpreted by two radiologists instead of one can lead to reduced recall rates and improved cancer detection, according to a new study published in Radiology. However, the authors noted, any additional cancers detected require “careful consideration” as they may be smaller, less likely to be invasive or less likely to have involved nodes.

A new option for training interventional radiologists in noninvasive procedures allows physicians to replicate patients’ blood vessels in a 3D-printed model, researchers announced at the Society of Interventional Radiology’s annual meeting in Los Angeles.

In a final rule that CMS said would help customers “suffering from high Obamacare premiums,” the agency’s 2019 rule for the Affordable Care Act (ACA) exchanges would give states more power on how plans cover required benefits and widen exemptions to the law’s individual mandate in the final year customers can be penalized for not having ACA-compliant insurance.

Insurance companies are beginning to decide what they’ll charge and whether to participate on the Affordable Care Act (ACA) exchanges for 2019, with Matt Eyles, the next CEO of America’s Health Insurance Plans (AHIP), saying it’s “not a pretty picture right now” for individual market insurers.

Bracco Diagnostics has filed a complaint with the U.S. International Trade Commission (ITC) against radiopharmaceutical firm Jubilant DraxImage and two affiliates, citing patent infringement on its rubidium-82 generators.

For all the attention given to forays from Amazon, Apple and Walmart into the healthcare space, traditional providers are more worried about the continued expansion of UnitedHealthGroup’s Optum into clinical care, according to an article in Bloomberg.

Imaging giant Bracco Diagnostics has filed a complaint with the U.S. International Trade Commission against Jubilant DraxImage, a Canadian radiopharmaceutical firm, requesting the ITC halt imports of Jubilant’s Ruby-Fill rubidium-82 generators and related components.